Combination Drugs: Their Use and RegulationLouis Lasagna |
Contents
FDA Policy J Richard Crout | 1 |
General Arguments for and against Drug Combinations F Gilbert McMahon | 8 |
Pharmacokinetic Considerations Gerhard Levy | 16 |
Copyright | |
19 other sections not shown
Common terms and phrases
active addition administration advantages adverse agents analgesic antibiotics antimicrobial anxiety appear appropriate asked aspirin associated basis better bination cause changes clinical combination drugs combination products compared components compounding consideration considered constituents containing controlled trials convenience cost decreased demonstrated depression disease doctors dosage dose drug combination effect efficacy enhanced equivalent evaluating evidence example experience fact fixed frequently give given going greater half-life important increase indicated individual infection ingredients involved Lasagna less levels major multiple narcotic opinion oral pain patients PETN physician placebo possible potential practice preparations prescribing prescription present problem prove question ratio reactions reasonable reduced regard relatively removed represent require response risk safe separately single situation specific studies subjects symptoms Table tablet therapeutic therapy things tions toxicity treated treatment